3
U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-QSB/A
AMENDMENT NO. 1
QUARTERLY REPORT UNDER SECTION 13 OR 15 (d) OF
THE SECURITIES AND EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 1995
Commission file number 1-12178
InnoVet, Inc.
(Exact name of small business issuer as specified in its charter)
Florida
(State or other jurisdiction
of
incorporation or organization)
14255 US 1, Suite 206
Juno Beach, Florida
(Address of principal
executive offices)
59-2699441
(I.R.S. Employer
Identification No.)
33408
(Zip Code)
(407) 626-6025
(Issuer's telephone number, including area code)
Check whether the issuer (1) filed all reports to be filed by
Section 13 or 15(d) of the Exchange Act during the past 12 months
(or for such shorter period that the registrant was required to
file such reports), and (2) has been subject to such filing
requirements for the past 90 days.
Yes X No _____
State the number of shares outstanding of each of the issuer's
classes of common equity, as of the latest practicable date:
Common Stock, $0.001 Par Value; 18,656,881 shares outstanding as
of November 12, 1995.
INDEX
INNOVET, INC.
PART II. OTHER INFORMATION
Page
Item 6. Exhibits
2
(a) This Amendment No. 1 reports the Financial Data
Schedule as required by
Item 601(c) of Regulation S-B. The Form 10-QSB
to which this Schedule
pertains was filed on November 15, 1995.
SIGNATURES 3
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned thereunto duly authorized.
InnoVet, Inc.
(Registrant)
/s/SCOTT P. CIELEWICH
Date: November 20, 1995 Scott P. Cielewich, Executive Vice
President and
Chief Financial Officer
WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.
<TABLE> <S> <C>
<ARTICLE>5
<CIK>0000821243
<MULTIPLIER>1
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-1995
<PERIOD-END> SEP-30-1995
<CASH> 7,702
<SECURITIES> 0
<RECEIVABLES> 42,371
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 66,608
<PP&E> 2,542
<DEPRECIATION> 0
<TOTAL-ASSETS> 198,565
<CURRENT-LIABILITIES> 279,846
<BONDS> 0
<COMMON> 18,657
0
0
<OTHER-SE> (99,938)
<TOTAL-LIABILITY-AND-EQUITY> 198,565
<SALES> 294,526
<TOTAL-REVENUES> 307,133
<CGS> 170,633
<TOTAL-COSTS> 606,996
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 40,625
<INCOME-PRETAX> (340,488)
<INCOME-TAX> 0
<INCOME-CONTINUING> (340,488)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (340,488)
<EPS-PRIMARY> (0.02)
<EPS-DILUTED> (0.02)
</TABLE>